Understanding the role of von Willebrand factor and its cleaving protease ADAM TS13 in the pathophysiology of critical illness

Pediatric Critical Care Medicine

Volumn 8, Issue 2, 2007, Pages 187-189

  Nguyen, Trung C ^a   Carcillo, Joseph A ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

ADAM TS13; Endothelium; Von Willebrand's disease

Indexed keywords

FIBRIN; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT RESPIRATORY DISTRESS SYNDROME; CRITICAL ILLNESS; EDITORIAL; ENDOTHELIUM INJURY; ENZYME ACTIVITY; LUNG CAPILLARY; LUNG INJURY; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHEAR STRESS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ACUTE DISEASE; ADAM PROTEINS; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; VON WILLEBRAND FACTOR;

EID: 34147166521     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000257468.75474.D4     Document Type: Editorial

References (19)

1. Furlan M, Robles R, Galbusera M, et al: von Willebrand factor cleaving protease in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. N Engl J Med 1998; 339:1578-1584
2. Moake JL: Thrombotic microangiopathies. N Engl J Med 2002; 347:589-600
3. Tsai HM, Lian EC: Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339:1585-1594
4. Bell WR, Braine HG, Ness PM, et al: Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 1991; 325:398-403
5. Rock GA, Shumak KH, Busund NA, et al: Comparison of plasma exchange with plasm infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991; 325:393-397
6. Moore JC, Hayward CP, Warkentin TE, et al: Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders. Blood 2001; 98:1842-1846
7. Veyradier A, Obert B, Houllier A, et al: Specific von Willebrand factor cleaving protease in thrombotic microangiopathies: A study of 111 cases. Blood 2001; 98:1765-1772
8. Ono T, Mimuro J, Madoiwa S, et al: Severe secondary deficiency of von Willebrand factor cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: Its correlation to development of renal failure. Blood 2006; 107:528-534
9. Busund R, Koukine V, Utrobin U, et al: Plasmapheresis in severe sepsis and septic shock: A prospective randomized controlled trial. Intensive Care Med 2002; 28:1434-1439
10. Kwan HC: Miscellaneous secondary thrombotic microangiopathy. Semin Hematol 1987; 24:141-147
11. Nguyen T, Hall M, Fiedor M, et al: Microvascular thrombosis in pediatric multiple organ failure: Is it a therapeutic target? Pediatr Crit Care Med 2001; 21:187-196
12. Stegmayr BG, Banga R, Berggren L, et al: Plasma exchange as rescue therapy in multiple organ failure including acute renal failure. Crit Care Med 2003; 31:1730-1736
13. Darmon M, Azoulay E, Thiery G, et al: Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange. Crit Care Med 2006; 34:2127-2133
14. Nguyen TC, Carcillo JA: Bench to bedside review: Thrombocytopenia associated multiple organ failure, a newly appreciated syndrome in the critically ill. Crit Care 2006; 19:235-243
15. Flori HR, Ware LB, Milet M, et al: Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation. Pediatr Crit Care Med 2007; 8:96-101
16. Anonymous ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342:1301-1308
17. Willson DF, Thomas NJ, Markovitz BP, et al: Pediatric Acute Lung Injury and Sepsis Investigators. JAMA 2005; 293:470-476
18. Motto D, Zhang W, Zhu G: Additional environmental and/or genetic factors are required to trigger TTP in ADAMTS13 deficient mice. Blood 2004; 104:258
19. Motto DG, Chauhan AK, Zhu G, et al: Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible mice. J Clin Invest 2005; 115:2752-2761